TFF2 and osteoarthritis: Prior studies outside of the context of bone irradiation have validated that upregulated osteoclast activity from other pathologies such as osteoporosis and osteoarthritis can modulate the expression of CGRP, SP, and/or NGF, contributing to pain sensitivity 35–37.